Clinical trial
Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and a Interruption Versus Continuation of Double Antiplatelet Therapy, One Year After Stenting
NCT00827411 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and a Interruption Versus Continuation of Double Antiplatelet Therapy, One Year After Stenting
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- January 31, 2013
- Enrollment
- 2,500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.